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Background: The assessment of adverse events from a patient-centered view includes patient-reported adverse
outcomes. An adverse outcome refers to any suboptimal outcome experienced by the patient; when adverse outcomes
are identified through a patient interview these are called patient-reported adverse outcomes. An adverse event is an
adverse outcome that is more likely due to the processes of medical care rather than to the mere progression of
disease. In the context of a large-scale study assessing post-hospitalization adverse events, we developed a conceptual
framework to assess patient-reported adverse outcomes (PRAOs). This methodological manuscript describes this
conceptual framework.
Methods: The PRAO framework builds on a validated adverse event ascertainment method including three phases:
Phase 1 involves an inquiry to ascertain the occurrence of any patient-reported adverse outcome. It is completed by a
structured telephone interview to obtain details – from a patient perspective – on symptoms that developed and/or
worsened after hospitalization. Phase 2 involves the classification of PRAOs by physicians not involved in the patient
care. Physician-reviewers then rate the PRAOs using well-adopted scales to determine whether the occurrence
was the natural progression of the underlying illness or due to medical care. When the PRAO is rated as “due to
medical care”, it is then classified as an “adverse event”. Phase 3 involves the classification of adverse events as
preventable or ameliorable.
Results: Out of the 1347 patients contacted at 1-month post-discharge, 469 reported AOs and after reviewing
369 cases, 29 were classified as AEs. Observed agreement levels between raters were 87.3, 85.5, and 85.2 %
respectively displaying a good agreement (k > 0.60).
Conclusion: The framework incorporates PRAOs as a way to identify cases that need to be evaluated for adverse
events. Further validation of this framework is warrant with the final aim of implementation at larger scale. The
implementation of this framework will enable clinicians, researchers and healthcare institutions to compare
outcome rates across providers and over time.
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Since the late 1990s when the Institute of Medicine re-
leased its influential report “To err is human”, there have
been increased efforts to enhance patient safety and to
quantify the rate of adverse events (AEs) [1]. The re-
ported rate of AEs for in-hospital patients ranges from
2.5 to 7.5 % [2, 3], although recent literature suggests
that these rates may be a gross underestimation, with
the actual rate ten times greater than previously reported
[4]. Two recent North American studies found an inci-
dence of post-hospital discharge AEs ranging from 19 to
23 % [5–7]. The discrepancies in these numbers high-
light the lack of a gold standard technique for determin-
ing and assessing AEs.
Indeed, various methods exist within the literature for
the collection and ascertainment of AEs, including self
[8–10] and incidence reporting, conduction of full retro-
spective patient record reviews, malpractice claims ana-
lyses and mortality and morbidity reviews [11, 12]. The
problem with these methods is that they are time inten-
sive, resource heavy, often identify different types of AEs
and miss injuries occurring in the post discharge period.
There has been a movement within the literature to
turn towards patients to help identify adverse events
[13–18]. Zhu et al., demonstrated that patients recognize
and accurately identify in-hospital adverse events [13].
In addition, Weingart et al. showed that many patient
identified events were not captured by traditional incident
reporting systems [14]. Furthermore, King et al. [18] dis-
cussed how the integration of patients’ perspectives facili-
tates the understanding of adverse events and suggest the
inclusion of patients’ perspective as a complementary
measuring tool.
Forster et al. [7] identified that one in five patients ex-
perienced an adverse event in the transition from hospital
to home, otherwise known as the post discharge period, a
period that is missed by the traditional methods of adverse
event ascertainment. These studies show the necessity of
involving patients to improve patient safety.
Forster et al. [7] developed a method where the patient
identified potential adverse events. Patients were con-
tacted within 2–5 weeks after discharged and were asked
to identify any new or worsening conditions, or other-
wise known as a patient reported adverse outcomes
(PRAO), as well as health services utilized. Patients who
identified a PRAO had a case summary prepared that
was reviewed by two board certified internists, to deter-
mine if an adverse event occurred [7]. In a follow up
study, the authors assessed the reliability of the peer re-
view process for the ascertainment of adverse events and
concluded that for the best agreement, at least three
similarly-trained reviewers are required [16].
This methodological paper describes the framework
developed for the assessment of patient-reported adverseoutcomes (PRAOs) occurring at the transition between
the hospital and the community. The framework is an
extension of the method developed by Forster et al. This
modified method substitutes the medical chart review,
for the review of patient cases that include clinical infor-
mation from discharge summaries and the patient re-
ports [6, 7, 16, 19–21].
Methods
The present study was nested in a large-scale randomized
clinical trial (RCT). This RCT assessed the efficacy of a
structured web-accessible electronic discharge sum-
mary being compared to usual care discharge summary
dictations [22, 23]. The full details of this RCT has been
described elsewhere [22]. This study uses data collected
during the RCT.
In this section we present the multi-phased method
included in the framework overview.
Framework overview
The conceptual framework for assessing PRAOs was
developed to aid in the understanding of concepts and
to act as a guide for future researchers conducting simi-
lar research [24]. Using an iterative process, we made
modifications to the approach designed by Forster et al.
[6, 7, 16, 20, 21] to enable the assessment of PRAO that
could be performed using hospital discharge summaries.
Figure 2 displays the framework, and its three phases of
information including, Phase 1 describes the identification
of PRAOs; Phase 2 includes two steps: 1) evaluating caus-
ation and severity of the PRAO. When the PRAO is likely
to be related to medical care (omission or commission)
then the PRAO is considered an adverse event; 2) using a
modified 6-point scale to assess whether the AE was
due to treatment/suboptimal medical care. [16]; Phase
3 classifies the identified AE as ameliorable, preventable
or neither.
We have clarified the terminology used to describe the
conceptual framework (Table 1).
The most important terms underlying the framework
are: adverse outcomes, patient-reported adverse outcomes
(PRAO), adverse events (AE), ameliorability, and prevent-
ability. Figure 1 is a schematic representation of how the
concepts relate to one another. An adverse outcome is
defined as any suboptimal outcome experienced by the
patient, including a new or worsening symptom, an un-
anticipated visit to a health facility, or death [6, 7]. Adverse
outcomes can be identified by medical record review or
through a patient interview. If captured only through the
latter, we define the outcomes as “patient reported adverse
outcomes” or PRAOs. An adverse event is an adverse out-
come that is more likely due to the processes of medical
care rather than by the mere progression of disease, where
medical care refers to all aspects of care including the
Table 1 Definition of terms
Term Definition
Adverse Outcome (AO) Any suboptimal outcome experienced by the patient, including a new or worsening symptom,
unanticipated visits to health facilities or death
Patient-reported Adverse Outcome (PRAO) Any suboptimal outcome experienced by the patient and reported directly by the patient
without interpretation of anyone else, which includes a new or worsening symptom,
unanticipated visits to health facilities or death
Adverse Event (AE) An adverse outcome caused by the processes of medical care rather than by the
progression of disease, where medical care refers to all aspects of care
Ameliorable Adverse Event (AAE) An injury whose severity could have been substantially reduced if different actions or
procedures had been performed or followed (unavoidable injuries but severity could have
been decreased)
Preventable Adverse Event (PAE) An injury that could have been avoided
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iorable adverse event is an outcome whose severity could
have been substantially reduced if different actions or pro-
cedures had been performed or followed [6, 7]. A prevent-
able adverse event, meanwhile, is an outcome that could
have been potentially avoided.
Phase 1: PRAO identification
In our study [22, 23], PRAO identification occurs at one
month post-hospitalization [24]. A trained interviewer
administers a brief structured interview over the tele-
phone that takes approximately ten minutes to complete.
The questionnaires (see Additional files 1, 2 and 3) gives
the patient an opportunity to describe new or worsening
health conditions as symptoms. We ask patients toPatient-reported Ad
Adverse E
Ameliorable
Fig. 1 Schematic representation of how the concepts described and assesdescribe: 1) timing of the onset of symptoms; 2) duration
of symptoms; 3) severity of the symptoms (on a 10-point
scale; 1 = not bothersome; 10 = bother a great deal).
Patients also explain the actions taken to alleviate the
symptoms, including their use of health services and
report if and how the symptom limited their usual
physical activities. The PRAO data generates a narra-
tive interview summary. This summary is used in sub-
sequent phases.
Phase 2: adverse event determination
The narrative interview summary is combined with in-
formation obtained from the electronic medical record
(specifically, the transfer-of-care summaries, otherwise
known as discharge summaries, related to the indexverse Outcomes
vents
Preventable
sed in the paper relate to one another
Table 2 Phase 2 agreements between reviewers prior to re-rating
on the dichotomous choice of whether the outcome was due to
medical management or not. (N = 369)
Agreement (%) Kappa (k) P-value
Reviewer 1 and 2 65.3 0.30 0.004
Reviewer 2 and 3 75.2 0.33 0.001
Reviewer 1 and 3 52.4 0.14 0.013
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erating a case report. This case report is used by the
physician raters to determine the cause of the adverse
event. Two physicians review the report independently
to determine whether the cause of the outcome was due
to the natural progression of the patient’s health condi-
tion or to the medical care received. Our team of re-
viewers consists of three academic physicians; two Royal
College certified internists and one College-certified
family physician.
During this phase, the physicians perform their classi-
fication of causation based on a simple dichotomous
choice (i.e. the outcome was likely caused by medical
care or not). If the PRAO is rated by the reviewing phys-
ician as being likely to have been caused by medical care,
it is then classified as an adverse event. Once a PRAO is
classified as an AE, the physician reviewers rate their
type. Type includes the following groups: adverse drug
events, procedure-related injuries, nosocomial infections,
care related falls, therapeutic errors, diagnostic errors, and
other. Severity is measured in terms of the impact on the
patient (how it affected the patient and how the patients
felt and functioned) and in terms of the impact on health
services used (e.g. visit to the emergency department).
Recognizing that a dichotomous assessment of relation
of a PRAO to medical care may be difficult, we also pre-
sented reviewers with a more nuanced 6-point scale for
judging the link of a PRAO to quality of medical care.
The 6-point scale’s response options are:
1 =No evidence that outcome was due to treatment
and/or suboptimal medical care;
2 =Little evidence that outcome was due to treatment
and/or suboptimal medical care;
3 =Outcome was possibly due to treatment and/or
suboptimal medical care (50/50 chance) but was
more likely due to disease;
4 =Outcome was possibly due to treatment and/or
suboptimal medical care (50/50 chance) and was
more likely due to treatment and/or medical care
than disease;
5 =Outcome was probably due to treatment and/or
suboptimal medical care;
6 =Outcome was definitely due to treatment and/or
suboptimal medical care.
Phase 3: preventability and ameliorability determinations
We then brought forward any cases with a rating of ≥5
on the above-mentioned 6-point scale to phase 3 for a
final evaluation step using Additional file 4. In this final
step, the physician reviewers were asked to classify
whether the adverse event is preventable, ameliorable or
neither, with definitions of these constructs as outlined
earlier.Ascertainment of agreement
Disagreements among reviewers can occur during
phases 2 and 3 of this multi-phased process. In phase 2,
when a disagreement between raters occurs, the raters
can meet face-to-face to come to a consensus. If a dis-
agreement persists, a third rater can act as a tiebreaker.
When using the 6-point scale as the primary tool for
determining link of a PRAO to medical care, reviewers
similarly need to review and discuss cases when their
ratings are disparate. This is needed when one physician
rates ≥5, while the other physician rates ≤3. If one phys-
ician rates ≥5 and the other rates 4, the higher rating is
endorsed and this is considered an AE. Similarly, when
one physician rates ≤3 while the other rates 4, the lower
rating is endorsed and this is not considered an AE.
Results
All patients admitted to a medical teaching unit in a
Canadian tertiary hospital were invited to participate in
the study [22]. During a period of 18 months, 1347 pa-
tients were interviewed to report any adverse outcome
that rose at one month after discharge from hospital. Of
these patients 469 reported adverse outcomes, 369 cases
were reviewed of which 29 were rated as adverse events
by the raters with an overall adverse event rate of 7.9 %.
Out of these, 11.5 % were preventable, 69.3 % were
ameliorable and 19.2 % were classified as neither pre-
ventable nor ameliorable.
All 369 cases were reviewed by at least 2 reviewers.
Reviewers 1, 2, and 3 each reviewed 266, 199, and 273
cases, respectively. Reviewers 1 and 2 rated a total of 96
cases between themselves; reviewers 2 and 3 rated 103
cases between themselves; and reviewers 1 and 3 rated a
total of 170 cases between themselves. Table 2 shows the
phase 2 agreements between raters prior to any re-rating
efforts, with observed agreement levels of 65.3, 75.2, and
52.4 % respectively, and corresponding kappa (k) values
of 0.30, 0.33 and 0.14, respectively. These kappa levels
indicate only slight to fair agreement [25]. After re-rating,
the observed agreement levels were 87.3, 85.5, and 85.2 %
respectively, and corresponding kappa (k) values of 0.62,
0.76 and 0.67 (p < 0,001) [25].
Table 3 shows the agreement between reviewers after
re-rating occurred using the 6-point scale of the PRAO
framework (Fig. 2). Reviewers 1 and 2 had a 94.8 %
Table 3 Phase 3 ratings from reviewers using the 6-point scale
of the PRAO framework after re-rating
Reviewer 1 Reviewer 2
1–2 3 4 5–6
1–2 37 17 8 0
3 7 8 1 2
4 1 0 2 0
5–6 1 2 3 7
N = 96, 94.8 % agreement, k = 0.82, p = 0.000
Reviewer 2 Reviewer 3
1–2 3 4 5–6
1–2 29 8 5 2
3 12 13 2 6
4 1 1 6 4
5–6 0 1 10 3
N = 103, 91.3 % agreement, k = 0.81, p = 0.000
Reviewer 1 Reviewer 3
1–2 3 4 5–6
1–2 50 30 31 2
3 6 11 0 2
4 0 0 4 4
5–6 3 8 8 11
N = 170, 91.8 % agreement, k = 0.74, p = 0.000
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had a 91.3 % agreement, k = 0.81 (p = 0.001) and reviewers
1 and 3 had a 91.8 % agreement, k = 0.74 (p = 0.001).
There were 21 cases that reviewers had full agreement on
after re-rating as being classified an AE due to medical
care (i.e. both reviewers rated the PRAO between a 5 and
6), which indicates an initial adverse event rate of 5.7 %.
There were 30 instances in which reviewers still dis-
agreed after meeting and reassessing cases (i.e. one re-
viewer rated that PRAO between 1 and 3, while the
other rated it between 5 and 6). In such instances, a
third reviewer assessed the case and this rating was
taken as final (Table 4).
To further illustrate the PRAO rating process, we have
provided real examples that can be found in Additional
file 5 (a, b, c). These examples include full agreement on
AE, agreement on not an AE, and an example of
disagreement.
Discussion
In this paper, we have refined and presented a conceptual
and methodological framework for the assessment of
PRAOs. The framework builds on a validated adverse
event ascertainment method, with modifications to stream-
line the process by including only the discharge summary
as well as the patient report [6, 7, 19, 20]. This methodidentifies PRAOs using a structured interview via the tele-
phone, classifies the cause of the PRAOs and determines if
it was due to medical care and whether the PRAO was
ameliorable or preventable. The framework presents a
potential tool to assess patient safety that can be used
by other groups such as healthcare quality improvement
management, and with wide spread adoption, it can help
standardize the ascertainment of AEs.
The importance of using PRAO in the ascertain-
ment of adverse events is highlighted in several stud-
ies [13–18, 26–28]. Traditionally it has been argued
that patients lack the expertise to evaluate care received
[28]. However, patients’ experiences and perceptions are
related to indicators such as access to medical care,
patient-provider communication, and transitions of care
[9, 27]. Positive patient experiences are linked to patient
health status [27], while negative patient experiences have
been linked to adverse health outcomes [5]. In addition,
patients are aware of adverse events and are often accurate
in reporting when adverse events have occurred. It has
also been found that patients report events that would
have been missed using standard chart review techniques
[14, 26, 27, 29, 30]. Utilizing PRAO can be a less costly
method for the identification of adverse events as com-
pared to the traditional methods. The novelty of this
framework is the incorporation of PRAOs as a way to
identify cases that needed to be evaluated for adverse
events [7]. To our knowledge, no framework has been
developed describing the assessment of adverse events
utilizing electronic transfer-of-care discharge summar-
ies and PRAO.
Many different methods exist within the literature for
the collection and ascertainment of AEs, but each method
is faced with limitations [3, 10, 31–33]. Self-reporting of
adverse events has been one common method utilized in
institutions, although voluntary reporting often underre-
ports the rate of AEs [10–12, 34]. Conducting full retro-
spective patient record reviews has been regarded by
some groups as the gold standard for the assessment of
AEs [33, 35]. This method typically consists of a two-
phase chart review process, involving a research nurse and
a physician rating adverse events [3, 10, 31–33]. This is an
onerous process that requires a significant amount of time
and resources, and relies on events having already oc-
curred or a healthcare professional identifying an event
[10]. Furthermore, this method does not capture post-
hospital AEs and excludes patients’ reports, which we
know are invaluable and capture missed events [13, 14].
Adverse event ascertainment is often time and resource
intensive, due to amount of documentation required from
the chart. In order to streamline the adverse event ascer-
tainment process, our framework proposes the use of hos-
pital discharge summaries as a key source of information
for PRAO assessments, supplemented by direct interviews
Fig. 2 Flow chart describing the evaluation process of a patient-reported adverse outcome (PRAO)
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summaries contain the necessary information required to
assess adverse events [36]. When Melton and Hripcsak
[37] compared assessments of adverse events using full
chart reviews versus discharge summaries, their resultsTable 4 Number of PRAOs that still resulted in disagreement
between two reviewers, which were rated by a third reviewer
Disagreement (%) Rated by Third Reviewer (N)
Reviewer 1 and 2 5.2 6
Reviewer 2 and 3 8.7 9
Reviewer 1 and 3 7.6 15a
aOne case that was a disagreement was not re-rated, but a third reviewer
rated it insteadshowed that the assessments were similar. Furthermore,
some studies have shown the potential for the use of auto-
mated detection systems that are able to scan discharge
summaries for adverse event triggers [36–40]. Electronic
transfer-of-care summaries can provide a platform for this
technology.
There are four limitations to this method of AE detec-
tion. Firstly, patients can report a large variation in the
amount of outcomes, not all of which are related to ad-
verse events. Previous studies have shown that approxi-
mately 50 % of patients will report an adverse occurrence
to an interviewer after being discharged from the hospital,
although the actual AE rate was 9 per 100 admissions
[14]. This high rate of PRAOs leads to a large volume of
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the burden to raters. Faced with this challenge, the use of
well-trained research assistants conducting patient follow
up calls is a potential solution.
Secondly, as with any retrospective study utilizing an
interview technique, there is a potential for recall bias.
To minimize recall bias, interviewers provide patients
with probes to assist recall along with possible responses
that offer patients set time frames around which they
can structure their answers [41–44]. For example, for
symptom duration, patients can report less than one
day, less than one week, less than two weeks, two weeks
or more, or still occurring. By proposing a standard
process for data collection and review, we hope that the
effect of this bias will be minimized. If all institutions
and researchers perform this work in the same way, then
the impact of this recall bias will be consistent.
Novick suggests that the traditional bias against tele-
phone interviews, low quality of data is not supported
by robust evidence [45]. This bias had been attributed to
the lack of visual cues during telephone interviews that
could potentially result in probing and interpretation
of responses. However on the other hand, telephone-
interviews may allow respondents to feel relaxed and
able to disclose sensitive information [45–47].
Thirdly, a known limitation within the traditional
methodology to ascertain AEs is the inter-rater reliability
within the point scale [6, 16, 48]. It has been our obser-
vation that different raters have varying exposures to
AEs resulting in each individual viewing a case differently.
It is for this reason that we have suggested incorporating
an “all-or-none” phenomenon, which leaves little room for
disagreement. However, if a point scale is used, we suggest
that reviewers are carefully chosen to have similar train-
ing, exposure to AEs, are from the same institution and
that regular and frequent meetings are conducted to en-
sure all reviewers have a firm understanding of the defini-
tions associated with AEs and what exactly is being rated.
Furthermore, we suggest that reviewers undergo a training
program similar to that used by Brennan and colleagues
to help improve inter-rater reliability [49]. While there is
debate within the literature concerning the reliability of
using one rater versus two or more, most studies suggest
that more than one reviewer is required to agree on a case
before the event can be classified as an AE [15, 48]. These
are all factors that can be modified as our knowledge of
optimal rating procedures improves.
Finally, we found in our study that in some instances
reviewers had difficulty deciding between a 3 (the out-
come was possibly due to treatment and/or suboptimal
medical care (50/50 chance) but was likely due to disease)
or a 4 (outcome was possibly due to treatment and/or sub-
optimal medical care (50/50 chance) and was more likely
due to treatment and/or medical management thandisease) response options on the 6-point scale. However,
raters recognized that the inclusion of both options was
important, as in ‘real world’ there are situations in which
is difficult to differentiate between disease progression and
treatment/medical management and the two options
make raters to consider this difference. Perhaps, testing a
modify version of this scale, compressing the scale to a
5-point scale (merging options 3 and 4) could be consider.
Any such adjustment of the 6-point scale to a 5-point
scale would require some retesting of the performance of
the revised scale in inter-observer agreement.
Adverse events are an important patient safety issue
and have become a focal point for research over the past
30 years. Despite the increased awareness surrounding
AEs, recent studies have pointed to the disappointing
numbers in AEs trends: rates have not been decreasing
significantly [50, 51]. A caveat to these findings, however,
is that standardized methodologies for the detection and
measurement of AEs need further development and
study. Our proposed framework can offer a standardized
method that incorporates patients’ views in the assess-
ment of adverse events. Future studies can focus on the
validity and reliability of this framework. Widespread
adoption of this tool can create a platform for future
researchers to compare AE statistic following patient
safety interventions.Conclusion
The framework presented here is an approach to deter-
mining AEs that can be used as a template by clinicians,
researchers and health care institutions. The data collected
using this framework could help health care systems in
their efforts to improve patient safety.Additional files
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